PRCT (PROCEPT BioRobotics) Float Percentage Of Total Shares Outstanding: 97.15% (As of Jun. 25, 2026)


PRCT PROCEPT BioRobotics Corp PRCT
70 GF Score
Price $20.85
GF Value $92.05
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PROCEPT BioRobotics Float Percentage Of Total Shares Outstanding?

PROCEPT BioRobotics PRCT +1.16% 70 Float Percentage Of Total Shares Outstanding is 97.15% as of Jun. 25, 2026. GuruFocus rates PRCT with a GF Score™ of 70/100 and a GF Value™ of $92.05 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PROCEPT BioRobotics's float shares is 55.30 Mil. PROCEPT BioRobotics's total shares outstanding is 56.92 Mil. PROCEPT BioRobotics's float percentage of total shares outstanding is 97.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PROCEPT BioRobotics's Insider Ownership is 3.83%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PROCEPT BioRobotics's Institutional Ownership is 107.51%.

PRCT
70GF Score
PROCEPT BioRobotics Corp PRCT
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PROCEPT BioRobotics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

PROCEPT BioRobotics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=55.30/56.92
=97.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 97.15% mean?
PROCEPT BioRobotics (PRCT) has a Float Percentage Of Total Shares Outstanding of 97.15% as of Jun. 25, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on PROCEPT BioRobotics and its competitors.
Is PROCEPT BioRobotics' Float Percentage Of Total Shares Outstanding too high?
PROCEPT BioRobotics' current Float Percentage Of Total Shares Outstanding is 97.15%. Overall, PROCEPT BioRobotics has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PROCEPT BioRobotics' Float Percentage Of Total Shares Outstanding compare to ALMR and AHCO?
PROCEPT BioRobotics' Float Percentage Of Total Shares Outstanding of 97.15% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on PROCEPT BioRobotics and its competitors. PROCEPT BioRobotics's current Float Percentage Of Total Shares Outstanding is 97.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PROCEPT BioRobotics stock overvalued right now?
Based on GuruFocus' analysis, PROCEPT BioRobotics (PRCT) is currently considered Significantly Undervalued. The stock's GF Value™ is $92.05, compared to a current price of $20.85 — trading 77.3% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 97.15%. PROCEPT BioRobotics' overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For PROCEPT BioRobotics (PRCT), the current Float Percentage Of Total Shares Outstanding is 97.15% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PROCEPT BioRobotics (PRCT) Overvalued in 2026?

Based on GuruFocus' analysis, PROCEPT BioRobotics stock appears to be undervalued. The current stock price of $20.85 is trading 77.3% below its estimated GF Value™ of $92.05. GuruFocus considers PROCEPT BioRobotics to be Significantly Undervalued.

Key valuation signals for PRCT:

  • Float Percentage Of Total Shares Outstanding: 97.15%
  • GF Value™: $92.05 vs. price of $20.85 (77.3% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the PRCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PROCEPT BioRobotics Business Description

Other Exchanges PRCT:Mexico
Address 150 Baytech Drive, San Jose, CA, USA, 95134
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
70GF Score

Get the complete analysis for PRCT

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.85
Price
$92.05
GF Value